Allelotype of gastric adenocarcinoma

Aron S. Yustein, Jeffery C. Harper, Gina R. Petroni, Oscar Cummings, Christopher A. Moskaluk, Steven M. Powell

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Yet, the underlying molecular events important in the development of this cancer are largely undefined. Thus, we performed a comprehensive survey for allelic loss on our panel of xenografted human gastric carcinomas. Contaminating normal stromal cells of primary cancers often limit mutational analyses. Xenografted samples of our gastric carcinomas provided optimally enriched tumors for neoplasia that clearly and sensitively demonstrated genetic alterations. Additionally, total absence of allelic signals in these xenografted samples confirmed true loss of alleles rather than just allelic imbalance. Analysis of at least two highly polymorphic microsatellite markers per nonacrocentric chromosomal arm in our xenografted human gastric carcinomas demonstrated significant loss of heterozygosity well above background levels at 3p, 4p, 5q, 8p, 9p, 13q, 17p, and 18q. Several of these loci represent novel findings of significant loss in gastric cancers. On chromosome 17p, p53 is known to be inactivated either by mutation or deletion in a majority of gastric carcinomas. The critical target(s) of inactivation in gastric cancers at these other loci remain to be characterized.

Original languageEnglish
Pages (from-to)1437-1441
Number of pages5
JournalCancer Research
Volume59
Issue number7
StatePublished - Apr 1 1999

Fingerprint

Stomach
Adenocarcinoma
Carcinoma
Loss of Heterozygosity
Neoplasms
Stomach Neoplasms
Allelic Imbalance
Sequence Deletion
Stromal Cells
Microsatellite Repeats
Chromosomes
Alleles
Mortality

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yustein, A. S., Harper, J. C., Petroni, G. R., Cummings, O., Moskaluk, C. A., & Powell, S. M. (1999). Allelotype of gastric adenocarcinoma. Cancer Research, 59(7), 1437-1441.

Allelotype of gastric adenocarcinoma. / Yustein, Aron S.; Harper, Jeffery C.; Petroni, Gina R.; Cummings, Oscar; Moskaluk, Christopher A.; Powell, Steven M.

In: Cancer Research, Vol. 59, No. 7, 01.04.1999, p. 1437-1441.

Research output: Contribution to journalArticle

Yustein, AS, Harper, JC, Petroni, GR, Cummings, O, Moskaluk, CA & Powell, SM 1999, 'Allelotype of gastric adenocarcinoma', Cancer Research, vol. 59, no. 7, pp. 1437-1441.
Yustein AS, Harper JC, Petroni GR, Cummings O, Moskaluk CA, Powell SM. Allelotype of gastric adenocarcinoma. Cancer Research. 1999 Apr 1;59(7):1437-1441.
Yustein, Aron S. ; Harper, Jeffery C. ; Petroni, Gina R. ; Cummings, Oscar ; Moskaluk, Christopher A. ; Powell, Steven M. / Allelotype of gastric adenocarcinoma. In: Cancer Research. 1999 ; Vol. 59, No. 7. pp. 1437-1441.
@article{f7154100350a43609158143c55598fba,
title = "Allelotype of gastric adenocarcinoma",
abstract = "Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Yet, the underlying molecular events important in the development of this cancer are largely undefined. Thus, we performed a comprehensive survey for allelic loss on our panel of xenografted human gastric carcinomas. Contaminating normal stromal cells of primary cancers often limit mutational analyses. Xenografted samples of our gastric carcinomas provided optimally enriched tumors for neoplasia that clearly and sensitively demonstrated genetic alterations. Additionally, total absence of allelic signals in these xenografted samples confirmed true loss of alleles rather than just allelic imbalance. Analysis of at least two highly polymorphic microsatellite markers per nonacrocentric chromosomal arm in our xenografted human gastric carcinomas demonstrated significant loss of heterozygosity well above background levels at 3p, 4p, 5q, 8p, 9p, 13q, 17p, and 18q. Several of these loci represent novel findings of significant loss in gastric cancers. On chromosome 17p, p53 is known to be inactivated either by mutation or deletion in a majority of gastric carcinomas. The critical target(s) of inactivation in gastric cancers at these other loci remain to be characterized.",
author = "Yustein, {Aron S.} and Harper, {Jeffery C.} and Petroni, {Gina R.} and Oscar Cummings and Moskaluk, {Christopher A.} and Powell, {Steven M.}",
year = "1999",
month = "4",
day = "1",
language = "English",
volume = "59",
pages = "1437--1441",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Allelotype of gastric adenocarcinoma

AU - Yustein, Aron S.

AU - Harper, Jeffery C.

AU - Petroni, Gina R.

AU - Cummings, Oscar

AU - Moskaluk, Christopher A.

AU - Powell, Steven M.

PY - 1999/4/1

Y1 - 1999/4/1

N2 - Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Yet, the underlying molecular events important in the development of this cancer are largely undefined. Thus, we performed a comprehensive survey for allelic loss on our panel of xenografted human gastric carcinomas. Contaminating normal stromal cells of primary cancers often limit mutational analyses. Xenografted samples of our gastric carcinomas provided optimally enriched tumors for neoplasia that clearly and sensitively demonstrated genetic alterations. Additionally, total absence of allelic signals in these xenografted samples confirmed true loss of alleles rather than just allelic imbalance. Analysis of at least two highly polymorphic microsatellite markers per nonacrocentric chromosomal arm in our xenografted human gastric carcinomas demonstrated significant loss of heterozygosity well above background levels at 3p, 4p, 5q, 8p, 9p, 13q, 17p, and 18q. Several of these loci represent novel findings of significant loss in gastric cancers. On chromosome 17p, p53 is known to be inactivated either by mutation or deletion in a majority of gastric carcinomas. The critical target(s) of inactivation in gastric cancers at these other loci remain to be characterized.

AB - Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Yet, the underlying molecular events important in the development of this cancer are largely undefined. Thus, we performed a comprehensive survey for allelic loss on our panel of xenografted human gastric carcinomas. Contaminating normal stromal cells of primary cancers often limit mutational analyses. Xenografted samples of our gastric carcinomas provided optimally enriched tumors for neoplasia that clearly and sensitively demonstrated genetic alterations. Additionally, total absence of allelic signals in these xenografted samples confirmed true loss of alleles rather than just allelic imbalance. Analysis of at least two highly polymorphic microsatellite markers per nonacrocentric chromosomal arm in our xenografted human gastric carcinomas demonstrated significant loss of heterozygosity well above background levels at 3p, 4p, 5q, 8p, 9p, 13q, 17p, and 18q. Several of these loci represent novel findings of significant loss in gastric cancers. On chromosome 17p, p53 is known to be inactivated either by mutation or deletion in a majority of gastric carcinomas. The critical target(s) of inactivation in gastric cancers at these other loci remain to be characterized.

UR - http://www.scopus.com/inward/record.url?scp=0033119770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033119770&partnerID=8YFLogxK

M3 - Article

C2 - 10197609

AN - SCOPUS:0033119770

VL - 59

SP - 1437

EP - 1441

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -